For the CA125 level, the differences were statistically significant between benign and subtypes of malignant tumors except the ovarian metastasis (p < 0.05 for them), and between a Stage II–IV OC and an ovarian borderline tumor (p = 0.019). Here, MUC16 is linked to cancer.